Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ketotifen Fumarate 0.25% Cream for Females With Secondary Vestibulodynia
NCT07257029Phase 2Recruiting
- Sponsor
- The Centers for Vulvovaginal Disorders
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketotifen in vestibulodynia, sponsored by The Centers for Vulvovaginal Disorders. Started Jan 2026; status: recruiting.
02
Drugs
ketotifen
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on NCT07257029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257029.